Lantz Financial
GSK icon

Lantz Financial’s GSK GSK Stock Holding History

Lantz Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,970
Closed -$208K – 267
2026
Q2 		$208K Buy
3,970
+98
+3% +$5.18K 0.04% 253
2026
Q1 		$214K Sell
3,872
-4,486
-54% -$243K 0.04% 232
2025
Q4 		$410K Sell
8,358
-2,257
-21% -$105K 0.09% 185
2025
Q3 		$458K Buy
10,615
+484
+5% +$18.9K 0.1% 164
2025
Q2 		$389K Buy
+10,131
New +$387K 0.1% 163
2020
Q3 		– Sell
-4,162
Closed -$212K – 121
2020
Q2 		$212K Sell
4,162
-2,010
-33% -$103K 0.15% 104
2020
Q1 		$292K Sell
6,172
-401
-6% -$21.4K 0.23% 88
2019
Q4 		$386K Sell
6,573
-477
-7% -$26.5K 0.23% 95
2019
Q3 		$363K Sell
7,050
-15
-0.2% -$772 0.25% 95
2019
Q2 		$361K Sell
7,065
-4,941
-41% -$248K 0.24% 94
2019
Q1 		$627K Buy
+12,006
New +$600K 0.45% 63

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Lantz Financial's GSK Position: Q3 2026 in Review

Lantz Financial sold out of GSK (GSK) in Q3 2026, closing a stake of 3,970 shares — an estimated $208K sold.

Lantz Financial first reported a position in GSK in Q1 2019 and held it in 11 quarters. The position peaked at $627K in Q1 2019. 246 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Lantz Financial reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Lantz Financial sold 3,970 GSK shares in Q3 2026, an estimated $208K.
  • Lantz Financial first reported a position in GSK in Q1 2019 and held it in 11 quarters.
  • Lantz Financial's GSK position peaked at $627K in Q1 2019.
  • 246 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Lantz Financial's 13F filing for Q3 2026, filed 15 Oct 2026.